Evaluation of an interferon inducer in viral respiratory disease.
D000917:Antibody Formation / Q000187:drug effects; D006801:Humans; D007372:Interferons / Q000032:analysis* / Q000097:blood; D009975:Orthomyxoviridae / Q000187:drug effects* / Q000302:isolation & purification; D011070:Poly I-C / Q000008:administration & dosage / Q000037:antagonists & inhibitors / Q000627:therapeutic use / Q000633:toxicity; D011119:Polynucleotides / Q000008:administration & dosage / Q000627:therapeutic use*; D012141:Respiratory Tract Infections / Q000097:blood / Q000188:drug therapy* / Q000382:microbiology; D012229:Rhinovirus / Q000187:drug effects* / Q000302:isolation & purification; D012260:Ribonucleases / Q000494:pharmacology
D011119:Polynucleotides; D007372:Interferons; D012260:Ribonucleases; D011070:Poly I-C